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ABSTRACT  
Objectives: Maternal dental periapical infections are associated with preterm birth and 
intrauterine growth restriction. This study investigates if the association is mediated through 
bacterial spread from periapical lesions to placenta (direct pathway) or systemic inflammatory 
reaction (indirect pathway). 
Materials and Methods: We compared birth outcomes in Malawian mothers with and without 
periapical infection. As markers of a direct pathway, we identified placental bacteria using a 16S 
rDNA approach, and assessed histological evidence of inflammation in the placenta and amniotic 
membranes. We measured C-reactive protein, alpha-1-acid glycoprotein and salivary cortisol as 
markers of an indirect pathway. We used regression models to associate the predictor variables 
with duration of pregnancy and newborn size.  
Results: Of 1024 women, 23.5% had periapical infection. There was no association of periapical 
infection with either bacterial DNA or histological inflammation in placenta or membranes.  
Periapical infection was associated with C-reactive protein, alpha-1-acid glycoprotein and 
cortisol concentrations in a dose-dependent manner at 36wk. Addition of alpha-1-acid 
glycoprotein or cortisol concentration into regression models attenuated the association between 
periapical infection and pregnancy outcomes.  
Conclusion: There was no evidence of direct spread of periapical bacteria to the placenta. 
Periapical infections and adverse pregnancy outcomes is in part mediated through systemic 
inflammation.  
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INTRODUCTION 
Every year 32 million infants are born too early or too small for their gestational age (Lee et al., 
2013). Of the 3.1 million annual global neonatal deaths, 35% are related to preterm birth (PTB) 
complications (Liu et al., 2012). The survivors are at risk of severe long term morbidity and 
development delay (Saigal & Doyle, 2008). Current interventions have largely failed to 
substantially impact the frequency of PTB and intrauterine growth restriction (IUGR) and 
indeed, PTB rates are still increasing in many countries (Chang et al., 2013). Several risk factors 
for PTB and IUGR have been identified of which maternal infections are among the most 
important. Yet the actual mechanisms by which these risk factors affect pregnancy are unclear 
(Goldenberg, Culhane, Iams, & Romero, 2008) which hampers the development of new, 
effective preventive approaches. 
 
Our previous study results from Malawi indicated an association between maternal dental 
periapical infections (PAI) and shorter pregnancy duration and smaller birth size (Harjunmaa et 
al., 2015). PAI commonly develops when a deep caries lesion exposes the pulp of the tooth 
allowing oral bacteria to enter the dental root canals, from where the infection eventually spreads 
to the bone surrounding the root (Nair, 2004). A causal relationship between PAI and pregnancy 
outcomes could be through both direct and indirect pathways, which are not mutually exclusive. 
Firstly, a direct pathway could exist whereby oral bacteria are disseminated through the blood 
stream to placental and fetal tissues, influencing birth outcomes through the generation of local 
inflammation, tissue damage or changes in placental function (Han & Wang, 2013; Romero, 
Dey, & Fisher, 2014). Secondly, bacteria within the oral cavity, could induce a systemic 
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inflammatory response that could affect the pregnancy indirectly. Although earlier studies have 
shown that bacteria can translocate from mouth to placenta (Aagaard et al., 2014), and it is 
known that PAI may lead to systemic inflammation (Gomes et al., 2013), there is no evidence 
that pathways from PAI to pregnancy complications actually exist. If they do, prevention and 
treatment of dental caries, the most common chronic disease globally that usually precedes PAI 
(Marcenes et al., 2013), would be a new and feasible intervention for prevention of PTB and 
IUGR. 
 
This study aimed to assess whether there is evidence of these two biologically plausible 
pathways between PAI and adverse pregnancy outcomes in a cohort of pregnant women from the 
iLiNS-DYAD study in Malawi (Harjunmaa et al., 2015). Our main hypothesis was that the 
associations between PAI and shortened duration of pregnancy, lower birth weight and smaller 
neonatal size are mediated through spread of the periapical bacteria to the feto-placental unit 
(direct pathway) or systemic inflammation (indirect pathway). We examined the direct pathway 
by assessing the prevalence and quantity of histological inflammation and bacteria in the 
placenta and chorioamniotic membranes. The indirect pathway was assessed by measuring 
concentrations of serum C-reactive protein (CRP) and alpha-1-acid glycoprotein (AGP) and 
salivary cortisol during pregnancy. CRP and AGP are acute phase proteins, produced in the liver 
in response to inflammatory stimuli, and have been associated with shortened duration of 
gestation and IUGR (Pitiphat et al., 2005; Tjoa et al., 2003). Cortisol is a steroid hormone 
released from the adrenal glands in response to emotional, physical or immunological stress 
(Bellavance & Rivest, 2014) and it also regulates the maintenance of pregnancy and the timing 
of parturition (Giurgescu, 2009; Voltolini & Petraglia, 2014). In this study, we investigated if the 
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shortened duration of pregnancy, smaller infant birth weight and neonatal size in women with 
PAI were mediated through these pathways. 
 
METHODS 
Study design, outcomes and ethics statement 
The present study represents continued analysis of a cross-sectional oral health sub-study that 
was nested within a randomized, controlled intervention trial, iLiNS-DYAD-M, in Malawi, Sub-
Saharan Africa (ClinicalTrials.gov, identifier NCT01239693). The trial was designed to examine 
the impact of home-fortification of pregnant women’s diets with lipid-based nutrient 
supplements on pregnancy outcomes and maternal and child health in a rural African 
community. Participants were enrolled prospectively into the main trial and followed throughout 
pregnancy. The oral health examination to assess the association between oral infections and 
birth outcomes was conducted after delivery.  
 
The outcome measures for the current study were duration of pregnancy, birth weight, neonatal 
length and neonatal head circumference. The potential intermediary variables were CRP, AGP 
and cortisol concentrations at 14-20 and at 36 gestation weeks (gw), prevalence of any or severe 
chorioamnionitis, prevalence of placental intervillositis, bacterial load and prevalence of 
common periapical bacteria in placental tissues and fetal membranes. 
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Written or thumb printed informed consent was taken from the participants at enrolment. Ethical 
approval was obtained from the College of Medicine Research and Ethics Committee, University 
of Malawi and the Ethics Committee of Pirkanmaa Hospital District, Finland (Protocol number 
P.08/10/972, date of approval 31st January 2011) 
 
Participants, enrollment and data collection 
Details of the main trial (Ashorn et al., 2015) and the oral health sub-study (Harjunmaa et al., 
2015) have been published previously. In brief, we enrolled 1391 pregnant women attending 
antenatal care before 20 gestational weeks between February 2011 and August 2012 through four 
health facilities in Mangochi District, southern Malawi. Participants received intermittent 
preventive malaria treatment with sulfadoxine–pyrimethamine at their first antenatal visit and 
between 28 and 34 gw as part of standard Malawian antenatal care. Research personnel assessed 
the duration of pregnancy with ultrasonography, performed health- and antenatal examinations 
and recorded participants’ medical and obstetric history and socioeconomic background. 
Participants who were enrolled in the main trial, had singleton pregnancies and completed the 
oral health examination were eligible for the oral health sub-study. Two dental therapists 
conducted full-mouth oral health examinations of the mothers and took digital panoramic 
radiographs of their jaws as soon as possible after delivery. A radiologist and an experienced 
dentists analysed the radiographs jointly. Research personnel recorded delivery events within 
48h after delivery and measured infant’s birth weight (BW). At 1-6 weeks after delivery, 
anthropometrists measured infant’s length, head circumference and neonatal weight.  
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Saliva and blood collection and processing 
Research nurses collected saliva and venous blood samples at the study clinic at baseline (14-20 
gw) and 36 gw. Saliva was collected after 30 min fast with a polymer swab placed under the 
tongue. Lab technicians measured salivary cortisol concentrations using an ELISA method and 
plasma CRP and AGP by immunoturbidimetry. Details of the saliva collection and processing 
are published elsewhere (Stewart et al., 2015). 
 
Placental tissue and fetal membrane collection and processing 
Two pieces of the chorionic and amniotic membranes were cut from the edge of the rupture site, 
and two full thickness pieces of placental tissue from near the umbilical cord insertion. One 
placental and one membrane sample were fixed in 10% formalin, embedded in paraffin wax, cut 
and stained with haematoxylin & eosin on glass slides for histological analysis. The remaining 
two samples were used for bacterial DNA analysis as published earlier (Doyle et al., 2017). In 
brief, all DNA extracted from the samples were screened for bacterial DNA using a qPCR 
targeting the V5-7 regions of the 16S rRNA gene (785F: 5′-GGATTAGATACCCBRGTAGTC-
3′, 1175R: 5′-ACGTCRTCCCCDCCTTCCTC-3′). Samples with detectable amounts of bacterial 
DNA were multiplexed, pooled, cleaned and sequenced. Paired-end sequenced reads were 
demultiplexed and assigned OTUs at 97% similarity against a small custom database of full 
length 16S rDNA sequences. Any sequences that failed to match at 97% were assigned against 
the full Greengenes database.  
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Definitions 
We diagnosed PAI if an unambiguous osteolytic finding (>1mm) related to the dental root apex 
was seen in the radiographs. We graded PAI as not present or present. We considered that a 
participant had PAI if at least one finding was recorded. We determined mild to moderate PAI as 
1-3 lesions and severe PAI as 4 lesions or more. We calculated infants’ sex-age-standardized 
length-for-age (LAZ), weight-for-age (WAZ) and head circumference-for-age Z-scores using the 
WHO Child Growth Standards. 
 
We considered high CRP concentration as CRP > 5 mg/L, high AGP concentration as AGP>1 
g/L and high cortisol concentration as >75th centile of all cortisol concentrations at that time 
point. We defined histological chorioamnionitis as ≥ 5 and severe chorioamnionitis as ≥ 25 
neutrophil granulocytes on average per 10 high power fields present in either the chorionic plate 
or the amniotic membrane. We defined acute intervillositis as ≥ 5 neutrophils and chronic 
intervillositis as ≥ 5 lymphocytes or monocytes on average per 10 high power fields in the 
placental intervillous space. We assessed presence of bacteria in the placental or fetal membranes 
by 16S rDNA broad-range SYBR green quantitative PCR assay. A result was positive for 
bacterial DNA if their Ct value was lower than 28 ± 3 cycles (equivalent to 40 CFU/µl) 
depending on variation between runs and determined using calibration curves generated from 
serial dilution of a known amount of Escherichia coli culture. 
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Statistical analysis  
We performed statistical analysis with Stata 12.1 (StataCorp, College Station, USA). We 
included in the analyses participants who completed the oral health visit within the 6 week 
puerperal period. The sample size was originally calculated for the main objective of the iLiNS-
DYAD-M trial. In the current analyses, we used the same sample of 1024 women as in our 
previous analyses on oral infections and birth outcomes that offered approximately 93% power 
to detect differences between the groups, assuming an infection prevalence of 25% and an effect 
size of 0.25 for continuous birth outcomes at 5% two-sided type I error rate (Harjunmaa et al., 
2015). 
 
We used multivariate linear regression to estimate adjusted means for continuous outcomes, and 
modified Poisson regression models (Zou, 2004) to estimate adjusted proportions for binary 
outcomes, and to estimate the associations between PAI and inflammation or infection variables 
(except bacterial prevalence and mean loads) and cortisol. The same covariates that were 
considered potential confounders of the relationship between oral infections and birth outcomes 
in our previous study (Harjunmaa et al., 2015) were used in this study for all outcomes to make 
the estimates comparable. We considered that these covariates were also biologically plausible 
confounders for the inflammation outcomes. The covariates were included in the models using 
forced entry method. The included covariates were maternal age, height, body-mass-index, 
socio-economic score (household assets), parity, time between delivery and the oral health 
examination, and number of teeth as continuous variables, and study site, nutrition intervention 
group, aenemia, HIV, malaria and periodontitis status as categorical variables. In addition, time 
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between wake-up and saliva collection, and time between last meal and saliva collection were 
used in cortisol analysis models as continuous variables. We added square terms for maternal 
height, BMI, age and socio-economic score into the models to test the assumption of linear 
relationships between continuous outcomes and covariates. Because adding non-linear covariates 
did not markedly improve the adjusted R-square, we excluded the non-linear terms from the final 
models. To assess if an inflammation variable was on a pathway between PAI and birth 
outcomes, we added those variables that were associated with PAI severity one by one in the 
models. We used White’s general test for heteroscedasticity to test for unequal variances using 
non-imputed data. The null hypothesis of homoscedasticity was not rejected. 
 
We used multiple imputed data (50 imputations) based on chained equation methods (van 
Buuren, Boshuizen, & Knook, 1999) for all multivariable model analyses. We imputed missing 
data for all variables that were included in the analyses, except for the 16S rRNA data. Cortisol 
concentration at 28wk was used in the imputation but not in the analyses themselves. The 
number of originally missing values that were substituted with values obtained by multiple 
imputation ranged from 0 to 371 (0.0% to 36.2%) per variable (supplementary table 1). 
 
We assessed the prevalence of any bacteria (bacterial 16S rRNA copies) in the placental and 
fetal membrane tissues by the PAI severity categories (no, mild-to-moderate and severe 
infection). Comparison between the groups was made with Fisher’s exact test. 
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We selected twenty-one periapical pathogen genera that are commonly mentioned in the 
literature (Fujii et al., 2009; Siqueira & Rocas, 2009; Somma, Castagnola, Bollino, & Marigo, 
2011) and compared their mean loads (mean number of 16S rRNA copies) and prevalence in the 
placental and fetal membrane tissues between participants who did not have and who had PAI. 
The selected bacteria genera were Actinomyces, Anaeroglobus, Atopobium, Bacteroides, 
Dialister, Enterococcus, Eubacterium, Filifactor, Fusobacterium, Mogibacterium, Olsenella, 
Parvimonas, Peptostreptococcus, Porphyromonas, Prevotella, Propionibacterium, 
Pseudoramibacter, Streptococcus, Tannerella, Treponema and Veillonella. Bacterial OTUs were 
first filtered at 0.01% mean relative abundance across samples and then clustered by genus. 
Tables of the particular genera were produced for women with both a sample and the dental 
assessment data. In the group comparisons, the Mann-Whitney U-test was used for the means 
and Fisher’s exact test for the prevalence. 
 
We assessed also the mean bacterial loads (mean number of 16S rRNA gene copies) of each 
bacteria genera found in the placentas or membranes of the mothers without or with PAI. 
Comparison of the mean values between the infection groups was made with Mann-Whitney U-
test. The analysis was adjusted by Benjamini-Hochberg equation to control the false discovery 
rate due to the number of comparisons.  
 
RESULTS 
A total of 1391 participants were enrolled in the iLiNS-DYAD study. Of those, 1229 (88.4%) 
completed the oral health examination between May 2011 and August 2013. After excluding 
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mothers with twins and those who completed the oral examination later than 6 wk after delivery, 
1024 (79.6%) participants were included in the analyses (supplementary figure 1.). The baseline 
characteristics of the included and excluded participants were similar except that the included 
women were on average slightly older (25 vs 24 y), less often primiparous (17.8% vs 33.3%) or 
malaria positive (21.4% vs 28.1%), and had a higher mean score for socio-economic status (0.46 
vs -0.13) and lower mean BMI (22.1 vs 22.4) (supplementary table 2.). The participant flow and 
the baseline characteristics have been published earlier (Harjunmaa et al., 2015). 
 
Among the included participants, the mean (SD) duration of pregnancy was 39.4 (2.3) gw, birth 
weight was 2979 (430) g and neonatal length was 49.7 (2.2) cm. The prevalence of PAI was 
23.5% (n=241). Mean (SD) time between delivery and oral examination was16.0 (8.0) days. The 
mean values for the laboratory measurements, histology findings and bacterial DNA of the 
participants are presented in table 1.   
 
Markers of a direct pathway 
There were no statistically significant differences between the PAI categories in any of the 
placental or fetal membrane histology-based inflammation markers. However, although 
statistically non-significant, the relative risk was usually higher when comparing the severe PAI 
group to the mild-to-moderate or no PAI groups, or the mild-to-moderate group to the no PAI 
group (table 2.).Similarly, no statistically significant differences were detected between the PAI 
categories in the prevalence of any bacteria in the placental (healthy 66.7%, mild-to-moderate 
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74.0% and severe 58.5% p=0.242) or membrane (healthy 44.8%, mild-to-moderate 53.7% and 
severe 38.6% p=0.470) samples. 
 
Out of the selected 21 bacteria genera that are commonly involved in PAI, 13 were found in both 
the fetal membranes and the placental tissues. However, there were no statistically significant 
differences between the groups of women with and without PAI in the mean bacterial loads 
(mean number of 16S rRNA copies) (table 3.) or in the prevalence of any of those bacteria 
genera (supplementary table 3.) that were found in at least 10 participants in the placental tissues. 
Similarly, no statistically significant differences between the PAI groups were found in the mean 
bacterial loads even when any bacteria genera that were found from the placental or membrane 
tissues were analyzed (data not shown). 
 
Markers of an indirect pathway 
There was a positive, dose-dependent association between PAI severity and the mean plasma 
concentrations of CRP, AGP and salivary concentration of cortisol at 36 gw. Compared to the no 
PAI group, women in the severe PAI group had 8.07 (0.40-15.75) mg/L higher mean CRP and 
1.90 nmol/L higher mean cortisol concentration, and women in the mild-to-moderate PAI group 
had 0.84 nmol/L higher mean cortisol concentration at 36 wk. No association was found with the 
14-20 wk samples (Table 4).No association was found with the 14-20wk samples (Table 4).  
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The patterns in the prevalence of elevated CRP, AGP and cortisol by PAI categories were similar 
to those for the continuous variables, except that the differences were statistically significant 
only for high cortisol at 36 gw (healthy 21.3%, mild-to-moderate 28.7%, severe 45.8%, p=0.033) 
(data not shown).  
 
Mediation of PAI – birth outcome association by systemic inflammation markers and 
cortisol 
In the primary analyses, women with PAI had 0.4 wk shorter mean pregnancy duration 
(p=0.015) and infants with 90 g lower mean BW (p=0.009) and 0.56 cm shorter mean neonatal 
length (p=0.002) compared to those who did not have PAI. Adjustment of the regression model 
for maternal AGP concentration at 36wk reduced the difference in means by 0.1 wk in the 
duration of pregnancy, 15 g in BW and 0.08 cm in neonatal length, and increased the p-values 
for each of the models. Adjustment for salivary cortisol concentration at 36 wk reduced the 
difference in pregnancy duration by 0.1 wk, BW by 10 g and neonatal length by 0.02 cm. When 
adjusting for both AGP and cortisol at the same time the results did not differ substantially from 
the AGP only adjustment, i.e. the effects were not additive. Adjustment for plasma CRP 
concentration or maternal severe chorioamnionitis did not markedly affect the strength of the 
association with any of the outcomes (table 5.). 
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DISCUSSION 
We aimed to investigate whether infection in placenta or within the chorioamniotic membranes 
(direct pathway) or systemic inflammation (indirect pathway) mediate the association between 
maternal PAI and shortened pregnancy duration, lower birth weight or smaller neonatal size. We 
did not find any evidence of a direct pathway linking periapical infection and pregnancy 
outcomes. However, PAI was associated with CRP, AGP and cortisol at 36 gw in a dose-
dependent manner. The associations between PAI and the adverse pregnancy outcomes were 
partially mediated by AGP and cortisol. 
 
Strengths and weaknesses 
Strengths of this study include a large sample size, rigorous quality control, multiple biological 
samples collected at various time points during pregnancy and after delivery, and clinical and x-
ray-based oral health assessment that allowed high quality diagnostics. The main weaknesses 
were some missing biological sample data, some differences in baseline characteristics between 
the participants who were included in analyses and those lost to follow-up, e.g. primiparity, and 
our inability to document the oral health status at baseline and immediately after delivery i.e. at 
the same time as the biological sample collection, due to ethical restrictions (e.g., exposure to x-
rays) and complexity of the study logistics in this low-resource context. In addition, the placental 
tissue of mothers who delivered very preterm was mostly not available, and naturally they did 
not undergo the 36gw sample collection. To reduce bias due to the loss-to-follow-up, we 
conducted adjusted analyses that included the baseline characteristics that distinguished the 
excluded and included participants, and imputed the missing data with multiple imputations 
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(excluding bacterial DNA). PAI was almost entirely related to large caries lesions that take 
several years to develop and are rarely treated in this low-resource setting, thus it is unlikely that 
their prevalence after delivery differed substantially from that at enrolment or 36gw. Finally, 
since the research team did not have the responsibility of providing the intermittent malaria 
treatment to the mothers, it was not possible to confirm if some participants received less than 
the standard amount of three doses. 
Placental infection 
In previous studies, bacteria, unequivocally demonstrated to have originated from infected root 
canals, have been isolated from blood (Debelian, Olsen, & Tronstad, 1996), (Debelian et al., 
1996), and in many studies found in the feto-placental unit, especially in preterm births (Han & 
Wang, 2013). While we did detect bacteria in placental tissue, previously reported to have 
originated from the oral cavity, we did not see any differences between those who did or did not 
have PAI. Furthermore, no differences were found in placental inflammation. This may be 
explained by the lack of samples from the pregnancies that ended in miscarriage and very early 
deliveries that took place at home where the tissues were discharged. 
 
Systemic inflammation  
Our study supports the earlier findings that PAI may induce systemic inflammatory responses 
(Gomes et al., 2013; Marton & Kiss, 2000; Somma et al., 2011), with elevated concentrations of 
CRP (Gomes et al., 2013) and AGP (de Soet et al., 2003; Glurich et al., 2002). We could not find 
any earlier studies linking PAI and cortisol concentrations, but cortisol concentrations have 
previously been associated with increased growth and virulence of oral pathogens (Jentsch, 
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Marz, & Kruger, 2013). In our study, the associations between PAI and the inflammatory 
markers and cortisol were stronger at 36wk than earlier in gestation. We believe that this finding 
relates to the alteration in the immune system during pregnancy. In early gestation the host 
immune responses are able to control local, low-grade infections, but pregnancy-related 
attenuation in the immune response increases the susceptibility to and consequences of infections 
in later gestation (Kourtis, Read, & Jamieson, 2014). The underlying mechanisms include limited 
T-cell activity (Taylor, Sullivan, Eblen, & Gercel-Taylor, 2002), decreased neutrophil functions 
and antibody production (Zachariasen, 1993), and hormonal changes which contribute to 
increased vascular permeability and bone resorption (Komm et al., 1988).  
 
Systemic inflammation, measured by elevated CRP concentration (Pitiphat et al., 2005; Tjoa et 
al., 2003), and salivary cortisol concentrations (Giurgescu, 2009) during pregnancy have 
previously been associated with shortened duration of gestation and IUGR. In line with those 
results, inflammation was associated with pregnancy outcomes also in our study sample. We also 
found that the association between PAI and adverse pregnancy outcomes was attenuated 
modestly when AGP or cortisol concentration was added in regression models, suggesting partial 
mediation of the association by the inflammatory pathway. The modest association may be 
related to the missed “before delivery” samples from those who delivered very early and who 
may have had more marked inflammation. Another important consideration is that our analyses 
were limited to the available markers, which may not have fully reflected systemic inflammation. 
Some oral-diseases-related salivary interleukins, immunoglobulins or metalloproteinases, 
released from infected periapical tissues (Gomes et al., 2013; Javaid, Ahmed, Durand, & Tran, 
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2016) and known to be associated with adverse pregnancy outcomes (Romero et al., 2014), 
might have been more sensitive markers.  
 
CONCLUSIONS 
The study findings suggest that PAI causes adverse pregnancy outcomes partially via an indirect 
pathway of systemic inflammation but not through a direct pathway of local placental infection.  
Further studies are needed to investigate whether the associations between PAI, elevated 
inflammatory markers and adverse birth outcomes are more pronounced when very early preterm 
deliveries are included. It is also important to study other inflammatory pathways and the impact 
of PAI elimination on pregnancy outcomes in future studies. 
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TABLES 
Table 1. Proportion of women with evidence of histological inflammation or bacterial infection 
in placenta, or systemic inflammation 
Outcome Proportion of women (n) 
Direct pathway  
Chronic placental intervillositis 1.9 % (19) 
Acute placental intervillositis 21.2% (217) 
Chorioamnionitis 19.9% (204) 
Bacterial DNA detected in chorioamniotic membranes 59.2% (606) 
Bacterial DNA detected in placental tissues 38.5% (394) 
Indirect pathway  
Elevated CRP concentration at 14-20 wk 39.1% (400) 
Elevated CRP concentration at 36wk 29.7% (304) 
Elevated AGP concentration at 14-20 wk 8.2% (84) 
Elevated AGP concentration at 36wk 4.5% (46) 
Elevated cortisol concentration at 14-20  23.8% (244) 
Elevated cortisol concentration at 36wk 23.6% (242) 
Abbreviations: PAI=periapical infection, CRP=C-reactive protein, AGP=alpha-1-acid glycoprotein, 
DNA=deoxyribonucleic acid
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Table 2. Prevalence of chronic and acute placenta intervillosis, any chorioamnionitis and severe chorioamnionitis by periapical 
infection severity. 
Outcome 
Prevalence of placental inflammation by 
participants’ PAI status* 
Comparison, mild-
to-mod vs no PAI 
Comparison, severe 
vs no PAI 
Comparison, severe 
vs mild-to-mod PAI 
No PAI  
n=783 
Mild to 
Moderate 
PAI n= 215 
Severe 
PAI n=26 
P-
value 
Risk ratio 
(95 % CI) P-value 
Risk ratio 
(95 % CI) P-value 
Risk ratio 
(95 % CI) P-value 
Chronic placental 
intervillositis  2.0% 2.6%  0.0% 0.883 
1.28  
(0.43-3.87) 
0.656 n/a n/a n/a n/a 
Acute placental 
intervillositis  15.8% 13.9% 29.9%   0.231 
0.88  
(0.54-1.44) 
0.513 1.90  
(0.85-4.22) 
0.116 2.15  
(0.93-4.97) 
0.072 
Chorioamnionitis, 
any (>4 cells)  25.8% 28.1% 26.7% 0.867 
1.09 
(0.79-1.51) 
0.596 1.04 
(0.46-2.34) 
0.934 0.95  
(0.42-2.15) 
0.899 
Chorioamnionitis, 
severe (>25 cells)  11.1% 14.6% 17.2% 0.407 
1.31  
(0.84-2.07) 
0.237 1.55  
(0.58-4.14) 
0.382 1.18  
(0.44-3.15) 
0.744 
PAI=periapical infection 
*Adjusted for HIV status, malaria status, height, body-mass index, age, study site, number of teeth, nutritional intervention group, aenemia, periodontitis status, 
household assets, oral health examination visit time 
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Table 3.Comparison of bacterial loads from selected genera that are commonly found in 
periapical infectious lesions, in the placenta and fetal membranes, presented by periapical 
infection status groups 
Bacterial genera in 
placental tissues 
Mean Log10 16S rRNA copies (SD) in 
placental tissues 
Mean Log10 16S rRNA copies (SD) in 
fetal membranes 
No PAI  
n=641 
PAI  
n= 188 P-value 
No PAI  
n=687 
PAI  
n=200 P-value 
Actinomyces 0.10 (0.53) 0.03 (0.27) 0.070 0.02 (0.26) 0 (0) 0.242 
Bacteroides 0.08 (0.53) 0.04 (0.37) 0.351 0.12 (0.72) 0.06 (0.40) 0.206 
Dialister 0.02 (0.22) 0.02 (0.21) 0.938 0.08 (0.52) 0.07 (0.54) 0.893 
Enterococcus 0.21 (0.92) 0.16 (0.81) 0.559 0.35 (1.20) 0.23 (0.98) 0.173 
Fusobacterium 0.17 (0.76) 0.08 (1.01) 0.120 0.14 (0.76) 0.11 (0.72) 0.605 
Parvimonas 0.01 (0.09) 0.09 (0.50) <0.001 0.12 (0.67) 0.17 (0.80) 0.394 
Peptostreptococcus 0.16 (0.69) 0.16 (0.69) 0.952 0.32 (1.11) 0.47 (1.36) 0.131 
Porphyromonas 0.13 (0.63) 0.09 (0.49) 0.418 0.04 (0.36) 0.01 (0.18) 0.253 
Prevotella 0.72 (1.42) 0.82 (1.56) 0.398 1.18 (1.86) 1.20 (1.89) 0.869 
Propionibacterium 0.25 (0.03) 0.35 (0.07) 0.197 0.13 (0.59) 0.07 (0.45) 0.135 
Streptococcus 0.52 (1.23) 0.59 (1.34) 0.481 1.02 (1.83) 1.08 (1.94) 0.680 
Treponema 0.06 (0.41) 0.06 (0.42) 0.959 0.15 (0.73) 0.15 (0.73) 0.922 
Veillonella 0.25 (0.89) 0.18 (0.76) 0.311 0.48 (1.33) 0.39 (1.12) 0.347 
PAI=Periapical infection 
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Table 4. Mean CRP, AGP and cortisol concentrations at 14-20wk and at 36wk of pregnancy by maternal periapical infection severity  
Outcome 
Mean (SD) concentration by 
participants’ PAI status* 
Comparison, mild-
to-mod vs no PAI 
Comparison, severe 
vs no PAI 
Comparison, severe 
vs mild-to-mod PAI 
No PAI  
n=783 
Mild to 
moderate 
PAI  
n= 215 
Severe 
PAI         
 n=26 
P-
value 
Difference 
in means 
 (95 % CI) 
P-
value 
Difference  
in means  
(95 % CI) 
P-
value 
Difference 
in means 
(95 % CI) 
P-
value 
CRP mg/L, 14-20wk 8.89 (19.13) 
8.82 
(16.00) 
11.85 
(18.93) 0.740 
-0.07 
(-3.06-2.93) 0.966 
2.96 
(-4.71-10.63) 0.449 
3.03 
(-4.75-10.81) 0.445 
CRP mg/L, 36wk  6.33 (14.81) 
8.68 
(17.06) 
14.41 
(19.00) 0.048 
2.35 
(-0.48-5.18) 0.104 
8.07 
(0.40-15.75) 0.039 
5.73 
(-2.06-13.51) 0.149 
AGP g/L, 14-20wk 0.72 (0.24) 
0.71 
(0.21) 
0.70 
(0.20) 0.926 
0.00 
(-0.04-0.03) 0.838 
-0.02 
(-0.11-0.08) 0.718 
-0.01 
(-0.11-0.08) 0.781 
AGP g/L, 36wk 0.57 (0.22) 
0.60 
(0.29) 
0.69 
(0.26) 0.040 
0.03 
(-0.01-0.07) 0.140 
0.12 
(0.02-0.23) 0.022 
0.09 
(-0.02-0.20) 0.093 
Cortisol nmol/L, 14-
20wk 
5.62 
(3.79) 
5.60 
(3.06) 
5.41 
(2.65) 0.963 
0.03 
(-0.56-0.63) 0.910 
-0.18 
(-1.70-1.34) 0.781 
-0.21 
(-1.71-1.29) 0.818 
Cortisol nmol/L, 
36wk 
7.97 
(2.91) 
8.85 
(4.62) 
9.87 
(3.24) 0.006 
0.84 
(0.19-1.50) 0.012 
1.90 
(0.25-3.36) 0.024 
1.06 
(-0.63-2.75) 0.218 
Abbreviations: CRP=C-reactive protein, AGP=Alpha-1-acid glycoprotein, PAI=periapical infection 
Mild to moderate PAI=1-3 lesions, severe PAI>3lesions 
*Adjusted for HIV status, malaria status, height, body-mass index, age, study site, number of teeth, nutritional intervention group, aenemia, periodontitis status, 
household assets, oral health examination visit time. Cortisol adjusted also for saliva collection time and time from last meal
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Table 5. Continuous birth outcomes by periapical infection status, adjusted for AGP, CRP, cortisol or both AGP and cortisol at 36gw, 
or chorioamnionitis  
Outcome 
Primary analysis* Adjusted for AGP 
Adjusted for   
CRP 
Adjusted for 
cortisol 
Adjusted for 
AGP and cortisol 
Adjusted for severe 
chorioamnionitis 
Women 
without 
PAI 
(n=783) 
Women 
with 
PAI 
(n=241) 
Difference 
in means 
(95%CI) 
P-
value 
Diff. in 
means
 
(95%CI) 
P-
value 
Diff. in 
means 
(95%CI) 
P-
value 
Diff. in 
means 
(95%CI) 
P-
value 
Diff. in 
means 
(95%CI) 
P-
value 
Diff. in 
means 
(95%CI) 
P-value 
Pregnancy duration 
(SD), gw  
39.5 
(2.05) 
39.1 
(2.60) 
-0.4 
(-0.8 to -
0.1) 
0.015 
-0.3  
(-0.7 to -
0.0) 
0.049 
-0.4  
(-0.8 to -
0.1) 
0.021 
-0.3  
(-0.7 to 
0.0) 
0.056 
-0.3  
(-0.7 to 
0.1) 
0.097 
-0.4 
(-0.7 to -
0.1) 
0.022 
Birth weight (SD), 
g  
2982  
(426) 
2891  
(415) 
-90 
(-157 to -
22) 
0.009 
-75  
(-142 to -
8) 
0.028 
-85  
(-153 to -
17) 
0.014 
-80  
(-149 to -
10) 
0.024 
-70  
(-139 to -
2) 
0.043 
-86  
(-153 to 
18) 
0.013 
WAZ (SD) 
-0.56 
 (1.03) 
-0.73 
 (1.07) 
-0.19 
(-0.35 to -
0.02) 
0.026 
-0.14  
(-0.31 to 
0.02) 
0.077 
-0.17  
(-0.34 to -
0.01) 
0.040 
-0.17 
(-0.34 to -
0.00) 
0.047 
-0.14 
(-0.31 to -
0.02) 
0.086 
-0.18 
(-0.34 to -
0.01) 
0.035 
Neonatal Length, 
cm (SD) 
49.7  
(2.19) 
49.2  
(2.28) 
-0.56 
(-0.92 to -
0.21) 
0.002 
-0.48  
(-0.83 to 
-0.13) 
0.007 
-0.54  
(-0.90 to -
0.18) 
0.003 
-0.54  
(-0.90 to -
0.17) 
0.004 
-0.49 
(-0.84 to -
0.13) 
0.008 
-0.54  
(-0.89 to -
0.19) 
0.003 
LAZ (SD) 
-0.98  
(1.10) 
-1.27  
(1.12) 
-0.29 
(-0.47 to -
0.11) 
0.001 
-0.25  
(-0.42 to 
-0.07) 
0.005 
-0.27  
(-0.46 to -
0.10) 
0.002 
-0.28  
(-0.47 to -
0.10) 
0.002 
-0.26  
(-0.43 to -
0.08) 
0.005 
-0.28  
(-0.46 to -
0.10) 
0.002 
Head Z (SD) 
-0.15  
(1.15) 
-0.38  
(1.24) 
-0.22 
(-0.41 to -
0.04) 
0.017 
-0.18  
(-0.37 to 
0.00) 
0.051 
-0.21  
(-0.41 to -
0.03) 
0.024 
-0.22  
(-0.41 to -
0.03) 
0.026 
-0.19  
(-0.41 to -
0.03) 
0.049 
-0.21  
(-0.5 to -
0.03) 
0.022 
PAI=Periapical infection, AGP=Alpha-1-acid glycoprotein, CRP=C-reactive protein, WAZ=weight-for-age z-score, LAZ=length-for-age z-score, Head Z=head 
circumference-for-age z-score 
31 
 
*Adjusted for HIV status, malaria status, height, body-mass index, age, study site, number of teeth, nutritional intervention group, aenemia, periodontitis status, 
household assets, oral health examination visit time 
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Supplementary figures and tables 
 
 
Supplementary figure 1. Participant flow in the iLiNS-DYAD Oral Health study. 
 
 
 
 
 
 
 
 
 
 
 
 
 
1391 enrolled women 
1229 completed oral health visit 
  162 loss to follow up 
1024 included in analyses 
205 excluded 
(11 twins, 194 visited>6wk) 
CRP  
1017 14-20wk 
888  36wk 
AGP 
1017 14-20wk 
888  36wk 
Cortisol 
999 14-20wk 
863  36wk 
Membranes 
807 birth 
Placenta tissue 
819 birth 
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CRP= C-reactive protein, AGP= alpha-1-acid glycoprotein  
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Supplementary table 1. Variables used in the analyses of the 1024 included participants 
Variable Variable type # imputed % imputed 
Acute intervillositis dichotomous 205 20.0% 
Anemia dichotomous 1 0.0% 
AGP 14-20 weeks continuous 7 0.7% 
AGP at 36 weeks continuous 137 13.4% 
Periapical infections categorical 0 0.0% 
Birth weight continuous 68 6.6% 
Chorioamnionitis dichotomous 217 21.2% 
Chronic intervillositis dichotomous 205 20.0% 
Cortisol 14-20 weeks continuous 25 2.4% 
Cortisol at 28 weeks continuous 286 27.9% 
Cortisol at 36 weeks continuous 161 15.7% 
CRP  14-20 weeks continuous 7 0.7% 
CRP at 36 weeks continuous 137 13.4% 
Gestational age at delivery continuous 0 0.0% 
Head circumference continuous 58 5.7% 
HIV status dichotomous 3 0.3% 
Intervention group categorical 0 0.0% 
Length of the infant continuous 57 5.6% 
Length-for-age z-score continuous 57 5.6% 
Maternal age continuous 0 0.0% 
Maternal bmi continuous 6 0.6% 
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Maternal height continuous 4 0.4% 
Maternal malaria dichotomous 2 0.2% 
Number of 16S rRNA copies in 
membranes continuous 137 13.4% 
Number of 16S rRNA copies in placentas continuous 195 19.0% 
Number of previous pregnancies continuous 2 0.2% 
Number of teeth continuous 1 0.0% 
Periodontitis status dichotomous 0 0.0% 
Research site categorical 0 0.0% 
Severe chorioamnionitis dichotomous 217 19.0% 
Socioeconomic score continuous 6 0.6% 
Time between delivery and oral health 
visit continuous 0 0.0% 
Time between meal and saliva collection 
at 28 weeks continuous 371 36.2% 
Time between meal and saliva collection 
at 36 weeks continuous 263 25.7% 
Time between meal and saliva collection 
14-20 weeks continuous 117 11.4% 
Time between waking up and saliva 
collection at 28 weeks continuous 371 36.2% 
Time between waking up and saliva 
collection at 36 weeks continuous 262 25.6% 
Time between waking up and saliva 
collection 14-20 weeks continuous 116 11.3% 
Weight-for-age z-score continuous 51 5.0% 
Years of education completed continuous 7 0.7% 
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Supplementary table 2. Baseline characteristics of the included and excluded participants 
Characteristic Included
b 
(n=1024) 
Excluded 
(n=367) P-value 
Mean (SD) maternal age, years 25 (6.2) 24 (5.7) <0.001 
Mean (SD) maternal education, 
completed years at school 
3.9 (3.4)                   
(7 missing data) 
4.3 (3.6)                  
(58 missing data) 0.087 
Mean (SD) proxy for socioeconomic 
statusa 
-0.13 (1.68)             
(6 missing data) 
0.46 (2.12)        
(62 missing data) <0.001 
Proportion of primiparous women, (n) 17.8% (182) 33.3% (122) <0.001 
Mean (SD) BMI, kg/m² 22.1 (2.7) 22.4 (3.1) 0.046 
Proportion of women with a low BMI 
(< 18.5 kg/m²), (n) 5.4% (55) 5.2% (19) 0.891 
Proportion of anemic women (Hb < 
110 g/l) (n) 19.8 % (203) 23.0% (84) 0.208 
Proportion of women with a positive 
HIV test, (n) 
14.1 % (144) 
(3 missing data) 
12.5 % (39) 
(54 missing data) 
0.460 
Proportion of women with a positive 
malaria test at enrollment (RDT), (n) 21.4% (219) 28.1% (103) 0.009 
Abbreviations: BMI=body-mass index, Hb=blood hemoglobin concentration, HIV=human immune deficiency virus, 
RDT=malaria rapid diagnostic test obtained from a finger-prick 
aCreated with principal components analysis by combining information on the building material of the house, main 
source of water and electricity, sanitary facility and main type of cooking fuel used 
bIncluded = visited<6wk after delivery, singleton pregnancy, data on at least one presented outcome 
Published earlier on: Harjunmaa U et al.  
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Supplementary table 3. Comparison of prevalence of selected bacteria that are commonly found in PAI lesions, in the placenta and 
fetal membranes, presented by periapical infection status groups 
Bacterial genera in 
placental tissues 
Prevalence (n) in placental tissues 
Bacterial genera in 
fetal membranes 
Prevalence (n) in fetal membranes 
No PAI  
n=641 
PAI  
n= 188 
P-value      
(chi-squared) 
No PAI  
n=687 
PAI  
n= 200 
P-value     
(chi-squared) 
Actinomyces 3.6% (23) 1.1% (2) 0.090 Actinomyces 0.7% (5) 0.0% (0) 0.593 
Bacteroides  2.2% (14) 1.1% (2) 0.546 Bacteroides 3.2% (22) 2.0% (4) 0.480 
Dialister 0.6% (4) 0.5% (1) 1.000 Dialister 2.3% (16) 2.0% (2) 1.000 
Enterococcus 5.3% (34) 4.3% (8) 0.706 Enterococcus 8.4% (58) 5.5% (11) 0.229 
Fusobacterium 5.3% (34) 2.7% (5) 0.170 Fusobacterium 3.5% (24) 2.5% (5) 0.652 
Parvimonas 0.2% (1) 3.2% (6) 0.001 Parvimonas 3.2% (22) 4.5% (9) 0.384 
Peptostreptococcus 5.0% (32) 5.3% (10) 0.851 Peptostreptococcus 8.6% (59) 11.5% (23) 0.213 
Porphyromonas 4.1% (27) 3.2% (6) 0.745 Porphyromonas 1.5% (10) 0.5% (1) 0.472 
Prevotella 21.2% (136) 22.9% (43) 0.616 Prevotella 30.3% (208) 30.0% (60) 1.000 
Propionibacterium 8.7% (56) 11.7% (22) 0.255 Propionibacterium 5.2% (36) 2.5% (5) 0.126 
Streptococcus 15.8% (101) 17.0% (32) 0.653 Streptococcus 25.5% (175) 25.5% (51) 1.000 
Treponema 2.0% (13) 2.1% (4) 1.000 Treponema 4.4% (30) 4.0% (8) 1.000 
Veillonella 7.5% (49) 5.3% (10) 0.334 Veillonella 12.4% (85) 10.5% (21) 0.537 
PAI=Periapical infection 
 
